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Introduction
Parry-Romberg syndrome (PRS) or progressive fa-
cial hemiatrophy was first described by Caleb Parry in 
1825 and Moritz Romberg in 1846 [1, 2]. This disorder is 
characterized by slowly progressing acquired unilateral 
hemifacial atrophy, which affects subcutaneous tissue 
together with the muscles and underlying bones. The 
pathogenesis and precise incidence of the syndrome 
remain unclear due to its rarity. Immune-mediated 
processes and disturbed central regulation, leading to 
the hyperactivity of the sympathetic nervous system, 
are primarily considered in the pathogenesis of this 
disorder [3]. Parry-Romberg syndrome and localized 
scleroderma are considered to be interrelated as both 
of them have a similar clinicopathological appearance 
[1, 4]. Also, trauma, viral infections, endocrine disorders, 
and alterations in brain lipid metabolism are believed to 
be associated with this disease. Progressive facial hemi-
atrophy is often described as coexisting with headache 
episodes, epilepsy (Jacksonian crises), and trigeminal 
neuralgia [2]. Ocular involvement in PRS is also often 
mentioned [5]. In rare cases, coexistence with contra-
lateral Poland syndrome was described [6].
Acquired homolateral segmental vitiligo is described 
as localized amelanotic patches in dermatomal distri-
bution, which do not cross the midline of the body. The 
disease is characterized by early onset and rapid stabili-
zation, and its pathogenesis is still unclear [7–10]. Neuro-
nal mechanisms, somatic mosaicism, and microvascular 
skin homing are proposed as mechanisms underlying 
segmental vitiligo [8].
Case report
A 46-year-old Caucasian man was admitted to the 
Dermatology Department at the University Hospital in 
Cracow complaining of vitiligo and hemifacial atrophy. 
The patient reported the first appearance of depigmen-
tation of the skin, involving the left upper limb and the 
left side of the trunk, at the age of 32 years. Lesions pro-
gressed, eventually affecting also the skin of the left side 
of the chin and neck. The lesions stabilized within a pe-
riod of 6 months and it was noted that the depigment-
ed area has not changed since then. At the age of 43, 
the patient first observed progressing atrophy of the left 
cheek with concomitant pain of the left jaw, ear, and eye. 
No history of trauma or injury to these sites was elicited 
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Abst rac t
Parry-Romberg syndrome or progressive facial hemiatrophy was first described by Caleb Parry in 1825 and Moritz 
Romberg in 1846. This disorder is characterized by slowly progressing acquired unilateral hemifacial atrophy, which 
affects subcutaneous tissue together with the muscles and underlying bones. The pathogenesis and precise inci-
dence of the syndrome remain unclear. Immune-mediated processes and disturbed central regulation, leading to 
the hyperactivity of the sympathetic nervous system, are primarily considered in the pathogenesis of this disorder. 
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clinicopathological appearance. We report the case of a 46-year-old man affected by both progressive atrophy of the 
left side of the face and homolateral, segmental vitiligo in the left side of the trunk and face.
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at the time of admitting the patient to the Department 
of Neurology. The patient underwent multiple diagnos-
tic procedures; the results were within normal ranges. 
Magnetic resonance imaging of the head did not reveal 
any focal lesions or signs of neurovascular incidents. 
Based on the clinical picture, trigeminal neuralgia was 
diagnosed and treatment with carbamazepine 200 mg 
D.T.S. was prescribed. Physical examination performed on 
admission to the Department of Dermatology revealed 
asymmetry of the face with visible left facial hemiatrophy 
including skin and subcutaneous tissue. The amelanotic 
lesions had a polydermatomal distribution (C2–T9), cov-
ering the left side of the trunk, upper left limb, and left 
side of the chin (Figures 1 and 2). Laboratory studies, in-
cluding complete blood count, erythrocyte sedimentation 
rate, C-reactive protein, blood chemistry, thyroid function 
tests, complement components C3, C4, C1q inhibitor, an-
ti-B2-glicoprotein antibodies, anti-Borrelia burgdorferi 
IgM and IgG antibodies, anti TPO, anti TG antibodies, lu-
pus anticoagulant, and urine analysis, were all negative 
or within normal ranges. Autoantibody detection using 
indirect immunofluorescence on HEp-2 cells revealed an-
tinuclear antibodies with granular staining pattern, titer 
1 : 640, and ANA with cytoplasmic 1 : 320 and mitotic 
spindle staining pattern 1 : 160 (normal limit < 1 : 160). 
Double immunodiffusion and immunoblot assays were 
negative. Standardized ELISA tests revealed increased 
plasma levels of IgG anti-cardiolipin antibodies: 42.85 
GPL (N: 0–10) with a negative IgM level. The results were 
confirmed after 6 weeks: 33.72 GPL (N: 0–10). X-ray of the 
cervical spine revealed no abnormalities.
Discussion
Parry-Romberg syndrome and acquired homolater-
al segmental vitiligo are two distinct disease entities of 
unknown etiology characterized by an onset in children 
and young adults, rapid progression followed by a sub-
sequent long period of stabilization, and dermatomal 
distribution [1, 2, 4, 11]. Acquired homolateral segmental 
vitiligo is described as localized amelanotic patches in 
dermatomal distribution, which do not cross the midline 
of the body. The lesions usually develop between the 
ages of 10 and 30 years. Most commonly, segmental vit-
iligo involves the face, trunk, neck, extremities, and scalp 
in the descending order of frequency. The pathogenesis 
of the disease remains unclear. Neuronal mechanisms, 
such as the dysfunction of the sympathetic nerves, are 
considered as most plausible among a variety of pro-
posed hypotheses [11, 12]. Additionally, somatic mosa-
icism and microvascular skin homing are proposed as 
underlying mechanisms of segmental vitiligo. Autoim-
mune processes are also considered to take part in the 
pathomechanism of vitiligo; although, it must be noted 
that segmental vitiligo is rarely associated with various 
autoimmune diseases as is the case for the non-segmen-
tal type [8]. In the presented case, first hypopigmented 
lesions were observed at the age of 32, and atrophy was 
11 years later. This may be considered a late onset for 
both diseases, potentially determining a mild course of 
the disease in the case of both syndromes. Parry-Rom-
berg syndrome, as described above, is characterized by 
a slowly progressing acquired unilateral hemifacial at-
rophy affecting the subcutaneous tissue, often together 
with the muscles and the underlying bones. Clinically, the 
skin of the affected area can be atrophic, dry, or hyper- 
or hypopigmented. In rare cases, skin lesions present 
a clear demarcation line between the normal and abnor-
mal skin; during the physical examination this has an 
appearance similar to a scar. More often, as illustrated 
Figure 1. Facial hemiatrophy and vitiligo of the chin
Figure 2. Vitiligo of the left upper limb and the left side of 
the trunk
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by the presented case, the border between affected and 
non-affected skin is indistinct. Occasionally, there may 
be areas of alopecia appearing in patients with hemifa-
cial atrophy, as well as ocular disturbances (most often 
enopthalmy due to the loss of periorbital fat), epilepsy, 
facial paresthesia, and other neurological disturbances. 
In the described patient, trigeminal neuralgia was diag-
nosed 1 year after the onset of facial atrophy. In more 
severe cases, often when the disease is noted to start at 
a younger age than in our patient, deviations of the nose, 
mouth, and dental midlines (appearing due to tissue at-
rophy) are observed. Parry-Romberg syndrome and lo-
calized scleroderma are considered to be interrelated as 
both of them have a similar clinicopathological appear-
ance [13–15]. The presence of antinuclear antibodies may 
suggest that PRS can be a variant of morphea. In our pa-
tient, anti-cardiolipin antibodies were elevated; this can 
occur in 2% of the healthy population [11]. A similar situ-
ation was presented by Bonifati et al. [11], who described 
a case of linear scleroderma and homolateral segmental 
vitiligo, where anti-cardiolipin antibodies were elevated. 
In both cases, no other criteria of the antiphospholipid 
syndrome were present.
In conclusion, it is difficult to define the correlation 
between PRS and homolateral segmental vitiligo. Our 
case is one of the few reported examples of the coexis-
tence of these two disease entities. Further studies are 
necessary to explain the coexistence of the common 
pathomechanism in PRS with homolateral vitiligo.
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